Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasYuchen Jiao, Laura D. Wood, Noushin Niknafs et al.|Nature Genetics|2013Cited by 709
Pancreatic Cancer and Immunotherapy: A Clinical OverviewFlorentine E. F. Timmer, Tanja D. de Gruijl, Bart Geboers et al.|Cancers|2021Cited by 127
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal CancerSietske C. van Nassau, Lieke H. J. Simkens, Marinde J. G. Bond et al.|JAMA Network Open|2021Cited by 10